Gold prices steady ahead of Fed decision, Trump’s tariff deadline
Investing.com -- The Senate officially confirmed Robert F. Kennedy Jr.’s nomination as secretary of Health and Human Services on Thursday. The final vote count was 52 in favor and 48 against, with Sen. Mitch McConnell being the only Republican to vote no. Democrats unanimously opposed Kennedy’s nomination.
Kennedy’s confirmation comes following months of intense debate and controversy, primarily due to his previous statements questioning the safety and effectiveness of vaccines.
This confirmation should impact vaccine stocks negatively, specifically Moderna Inc (BMV:MRNA). (NASDAQ:MRNA), Pfizer Inc. (NYSE:PFE), and BioNTech (NASDAQ:BNTX). These companies have seen their stocks continually decline as Kennedy’s nomination was announced by President Trump and gained momentum. As of now, these stocks are rising, Moderna up 1.9%, Pfizer up 0.5%, BioNTech up 4.6%, as investors seem to be ’buying the news’.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.